Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK
JB Capital LLC increased its stake in Merck & Co., Inc. by 11.5% in the third quarter, now holding 127,915 shares valued at approximately $10.74 million. Other major institutions also adjusted their positions, and around 76.07% of Merck's stock is institutionally owned. Merck recently raised its quarterly dividend to $0.85 per share, resulting in an annualized dividend of $3.40 and a yield of 3.2%.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Stonebridge Financial Group LLC Has $638,000 Position in Merck & Co., Inc. $MRK
Stonebridge Financial Group LLC significantly reduced its stake in Merck & Co., Inc. by 76.8% in Q3, now holding shares valued at $638,000. This comes as Merck announced an increase in its quarterly dividend to $0.85 per share, yielding approximately 3.2% annually. Several other institutional investors adjusted their holdings in MRK, and an executive also trimmed his position.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Los Angeles Capital Management LLC Buys 956,879 Shares of Merck & Co., Inc. $MRK
Los Angeles Capital Management LLC significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) by 39%, purchasing 956,879 additional shares. This brings their total holdings to 3,412,448 shares, valued at approximately $286.4 million, making Merck their 14th largest position. The article also notes Merck's increased quarterly dividend and several analyst upgrades with higher price targets, despite the consensus remaining a "Hold" rating.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Sax Wealth Advisors LLC Increases Position in Merck & Co., Inc. $MRK
Sax Wealth Advisors LLC significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) by 76.5% in the third quarter, bringing its total holdings to 29,338 shares valued at $2,462,000. This move is part of a broader trend of institutional investors adjusting their positions in MRK, with several other firms also increasing their holdings. Analysts have a consensus "Hold" rating for Merck & Co., Inc. with an average price target of $110.13, following various target price adjustments and ratings from different investment banks.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
VIRGINIA RETIREMENT SYSTEMS ET Al Has $126.51 Million Stock Holdings in Merck & Co., Inc. $MRK
VIRGINIA RETIREMENT SYSTEMS ET Al significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) by 3.6% in the third quarter, bringing its total holdings to 1,507,338 shares valued at $126.51 million. The stock represents 0.8% of the retirement system's portfolio and 0.06% of Merck & Co., Inc. Merck & Co., Inc. has also seen other institutional investor activity and recently increased its quarterly dividend to $0.85 per share.
Dec 31, 2025 • MarketBeat
NEUTRAL
Smith Salley Wealth Management Reduces Stock Holdings in Merck & Co., Inc. $MRK
Smith Salley Wealth Management significantly reduced its stake in Merck & Co., Inc. by 74.9% during Q3, selling 115,841 shares and retaining 38,842 shares valued at $3.26 million. Despite recent analyst upgrades and increased price targets, MarketBeat's consensus rating for MRK remains "Hold" with an average price target of $110.13. Additionally, a Merck EVP sold a portion of his shares, while other institutional investors have modified their holdings, and the company recently increased its quarterly dividend.